XML 21 R7.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Statements Of Cash Flows - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Cash flows - operation activities:    
Net earnings/(loss) $ 985 $ 2,446
Non-cash items –    
Share-based plans expense 97 94
Depreciation and amortization 890 912
Investment/asset impairment charges, net 50 74
Customer financing valuation benefit (4) (5)
Gain/(loss) on dispositions, net 9 (1)
Other charges and credits, net 141 140
Excess tax benefits from share-based payment arrangements (124)
Changes in assets and liabilities –    
Accounts receivable (503) (313)
Inventories, net of advances and progress billings 3,004 (2,395)
Accounts payable 1,221 888
Accrued liabilities (269) (177)
Advances and billings in excess of related costs (954) 195
Income taxes receivable, payable and deferred (494) 482
Other long-term liabilities (103) (17)
Pension and other postretirement plans 181 1,244
Customer financing, net 275 19
Other (61) (77)
Net cash provided by operating activities 4,465 3,385
Cash flows – investing activities:    
Property, plant and equipment additions (1,419) (1,266)
Property, plant and equipment reductions 13 20
Payments to Acquire Businesses, Net of Cash Acquired (23)
Contributions to investments (657) (1,205)
Proceeds from investments 705 2,040
Other 8 22
Net cash used by investing activities (1,350) (412)
Cash flows – financing activities:    
New borrowings 1,323 761
Debt repayments (267) (846)
Stock options exercised 147 276
Excess tax benefits from share-based payment arrangements 124
Employee taxes on certain share-based payment arrangements (79) (90)
Common shares repurchased (5,501) (4,501)
Dividends paid (1,408) (1,264)
Proceeds from (Payments for) Other Financing Activities (24)
Net cash used by financing activities (5,809) (5,540)
Effect of exchange rate changes on cash and cash equivalents (3) (9)
Net decrease in cash and cash equivalents (2,697) (2,576)
Cash and cash equivalents at beginning of year 11,302 11,733
Cash and cash equivalents at end of period $ 8,605 $ 9,157